Adhesion molecules in clinical medicine

Critical Reviews in Clinical Laboratory Sciences

Volumn 35, Issue 5, 1998, Pages 415-459

  Cavenagh, Jamie D ^a   Cahill, Mary R ^a   Kelsey, Stephen M ^a  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

Apoptosis; Hemopoiesis; Immunoglobulin superfamily; Inflammation; Integrins; Leukemia; Neutrophil migration; Selectins; Thrombosis

Indexed keywords

CELL ADHESION MOLECULE; CYTOKINE;

BONE MARROW; EMBRYO DEVELOPMENT; HEMATOPOIETIC STEM CELL; INFLAMMATION; LEUKOCYTE; LYMPHOCYTE FUNCTION; LYMPHOCYTE HOMING; METASTASIS; PRIORITY JOURNAL; REVIEW; THROMBOCYTE; TISSUE REPAIR; VASCULAR ENDOTHELIUM;

ANTIBODIES, MONOCLONAL; APOPTOSIS; BLOOD PLATELETS; CADHERINS; CELL ADHESION MOLECULES; ENDOTHELIUM, VASCULAR; HEMATOPOIESIS; HUMANS; IMMUNOGLOBULINS; INTEGRINS; LEUKOCYTES; PROTEOGLYCANS; SELECTINS;

EID: 0031727401     PISSN: 10408363     EISSN: None     Source Type: Journal    
DOI: 10.1080/10408369891234237     Document Type: Review

References (237)

1. Gearing AJH, Newman W. Circulating adhesion molecules in disease. Immunol Today 1993; 14: 506-512.
2. Springer TA. Adhesion receptors of the immune system. Nature 1993; 346: 425-434.
3. Garrod DR. Cell to cell and cell to matrix adhesion. Br Med J 1993; 306: 703-5.
4. Shimuzu Y, Shaw S. Mucins in the mainstream. Nature 1993; 366: 630-631.
5. Williams AF, Barclay AN. The immunoglobulin superfamily. Annu Rev Immunol 1988; 6: 381-394.
6. Hogg N, Bates PA Harvey J. Structure and function of intercellular adhesion molecule-1. Chem Immunol 1991; 50: 98-103.
7. Marlin SD, Springer TA. Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1). Cell 1987; 51: 813-819.
8. Smith CW, Rothlein R, Hughes BJ, et al. Recognition of an endothelial determinant for CD18-dependent human neutrophil adherence and transendothelial migration. J Clin Invest 1988; 82: 1746-1756.
9. Diamond MS, Staunton DE, Marlin SD, et al. Binding of the integrin Mac-1 (CD11b/CD18) to the third Ig-like domain of ICAM-1 (CD54) and its regulation by glycosylation. Cell 1991; 65: 961-965.
10. Bevilacqua MP, Pober JS, Wheeler ME, et al. Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes and related leukocyte cell lines. J Clin Invest 1985; 76: 2003-2011.
11. Dejana E, Bertocchi F, Bortalami MC, et al. Interleukin 1 promotes tumour cell adhesion to cultured human endothelial cells. J Clin Invest 1988; 82: 1466-1470.
12. Moser R, Schleiffenbaum B, Groscurth P, et al. Interleukin 1 and tumor necrosis factor stimulate human vascular endothelial cells to promote trans-endothelial neutrophil passage. J Clin Invest 1989; 83: 444-455.
13. Dejana E, Bussolino F, Wang JM, et al. Cytokine regulation of endothelial cells In: Balkwill FR Ed. Cytokines: a practical approach 15. Pp. 215-228. Oxford: Oxford University Press, 1991.
14. Hahne M, Jager U, Isenmann S, et al. Five tumor necrosis factor-inducible cell adhesion mechanisms on the surface of mouse endothelioma cells mediate the binding of leukocytes. J Cell Biol 1993; 121: 655-664.
15. Pober JS, Berilacqua MP, Mendrick DL, et al. Two distinct monokines, interleukin 1 and tumor necrosis factor, independently induce biosynthesis and transient expression of the same antigen on the surface of cultured human vascular endothelial cells. J Immunol 1986; 136: 1680-1685.
16. Pober JS, LaPierre LA, Stolpen AH, et al. Activation of cultured human endothelial cells by recombinant lymphotoxin: comparison with tumor necrosis factor and interleukin 1 species. J Immunol 1987; 13: 3319-3323.
17. Staunton DE, Merluzzi VJ, Rothlein R, et al. A cell adhesion molecule, ICAM-1, is the major surface receptor for rhinoviruses. Cell 1989; 56: 849-853.
18. Staunton DE, Dustin ML, Erikson HP, et al. The arrangement of the immunoglobulin-like domains of ICAM-1 and the binding sites for LFA-1 and rhinovirus. Cell 1990; 61: 243-247.
19. Berendt AR, Simmons DL, Tansey J, et al. Intercellular adhesion molecule -1 is an endothelial cell adhesion receptor for Plasmodium falciparum. Nature 1989; 341: 57-59.
20. Staunton DE, Dustin ML, Erikson HP, et al. Functional cloning of ICAM-2, a cell adhesion ligand for LFA-1 homologous to ICAM-1. Nature 1989; 339: 61-64.
21. de Fougerolles AR, Stacker SA, Schwarting R, et al. Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-A. J Exp Med 1991; 174: 253-67.
22. Osborn L, Hession C, Tizard R, et al. Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell 1989; 59: 1203-1211.
23. Hession C, Tizard R, Vassallo C, et al. Cloning of an alternate form of vascular cell adhesion molecule-1 (VCAM1). J Biol Chem 1991; 266: 6682-6685.
24. Hemler ME. VLA proteins in the integrin family: structures, functions and their role on leukocytes. Annu Rev Immunol 1990; 8: 365-400.
25. Briskin MJ, McEvoy LM Butcher EC. MAdCAM-1 has homology to immunoglobulin and mucin-like adhesion receptors and to IgA1. Nature 1993; 363: 461-464.
26. Berlin C, Berg EL, Briskin MJ, et al. a4β7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell 1993; 74: 185-197.
27. Sikovski EE, Hallmann R, Berg EL, et al. The Peyer's patch high endothelial receptor for lymphocytes, the mucosal vascular addressin, is induced on a murine endothelial cell line by tumor necrosis factor-a and IL-1. J Immunol 1993; 151: 5239-5250.
28. Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood 1994; 84: 2068-2101.
29. Muller WA, Weigl SA, Deng X, et al. PECAM-1 is required for transendothelial migration of leukocytes. J Exp Med 1993; 178: 449-454.
30. Conforti G, Zanetti A, Pasquali-Ronchetti I, et al. Modulation of vitronectin receptor binding by membrane lipid composition. J Biol Chem 1990; 265: 4011-4019.
31. Sharma CP, Magil S Arnaout MA. Microdomains in the cytoplasmic tail of CD18 involved in binding to cytoskeleton. Clin Res 1992; 40: 434A.
32. van den Berg TK, van der Ende M, Dopp EA, et al. Localization of β1 integrins and their extracellular ligand in human lymphoid tissues. Am J Pathol 1993; 143: 1098-1110.
33. Hemler ME, Huang C, Takada Y, et al. Characterization of the cell surface heterodimer VLA-4 and related peptides. J Biol Chem 1987; 262: 11478-11485.
34. Bohnsack JF, Zhou X-N. Divalent cation substitution reveals CD18- and very late antigen-dependent pathways that mediate human neutrophil adherence to fibronectin. J Immunol 1992; 149: 1340-1347.
35. 1 heterodimer. J Leuk Biol 1993; 53: 576-582.
36. Elices MJ, Hemler ME. The human integrin VLA-2 is a collagen receptor on some cells and a collagen/laminin receptor on others. Proc Natl Acad Sci USA 1989; 86: 9906-9910.
37. Vonderheide RH, Springer TA. Lymphocyte adhesion through very late antigen 4: Evidence for a novel binding site in the alternatively spliced domain of vascular cell adhesion molecule 1 and an additional α4 integrin counter-receptor on stimulated endothelium. J Exp Med 1992; 175: 1433-1442.
38. Arnaout MA. Structure and function of the leukocyte adhesion molecules CD11/ CD18. Blood 1990; 75: 1037-50.
39. Larson RS, Springer TA. Structure and function of leukocyte integrins. Immunol Rev 1990; 114: 181-217.
40. Diamond MS, Alon R, Parkos CA, et al. Heparin is an adhesive ligand for the leukocyte integrin Mac-1 (CD11b/CD18). J Cell Biol 1995; 130: 1473-1482.
41. Ruf A, Patscheke H. Platelet-induced neutrophil activation: platelet-expressed fibrinogen induces the oxidative burst in neutrophils by an interaction with CD11c/CD18. Br J Haematol 1995; 90: 791-796.
42. 7integrin mediates B cell adhesion to fibronectin and vascular cell adhesion molecule-1. J Immunol 1993; 151: 2471-2475.
43. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994; 76: 301-314
44. Springer TA. Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu Rev Physiol 1995; 57: 827-872.
45. Hynes RO. Integrins: a family of cell surface receptors. Cell 1987; 48: 549-554.
46. Heidemann SR. A new twist on integrins and the cytoskeleton. Science 1993; 260: 1080-1081.
47. Smyth SS, Joneckis CC Parise LV. Regulation of vascular integrins. Blood 1993; 81: 2827-2843.
48. Clark EA, Brugge JS. Integrins and signal transduction pathways: the road taken. Science 1995; 268: 233-239.
49. Lub M, van Kooyk Figdor CG. In and outs of LFA-1. Immunol Today 1995; 16: 479-483.
50. Calvete JJ. Clues for understanding the structure and function of a prototypic human integrin: the platelet glycoprotein IIb/IIIa complex. Thromb Haemost 1994; 72: 1-15.
51. 11b. Science 1991; 254: 845-847.
52. Rabb H, Michishita M, Sharma CP, et al. Cytoplasmic tails of human complement receptor type 3 (CR3, CD11b/CD18) regulate ligand avidity and the internalization of occupied receptors. J Immunol 1993; 151: 990-1002.
53. Chatila T, Geha RS Arnaout MA. Constitutive and stimulus-induced phosphorylation of CD11/CD18 leukocyte adhesion molecules. J Cell Biol 1989; 109: 3435-3444.
54. Shattil SJ, Brugge JS. Protein tyrsoine phosphorylation and the adhesive functions of platelets. Curr Opin Cell Biol 1991; 3: 869-879.
55. 2+ in human neutrophils: initiation by adherence receptors of the integrin family. J Cell Biol 1991; 112: 1249-1257.
56. Bevilacqua M, Butcher E, Furie B, et al. Selectins: a family of adhesion receptors. Cell 1991; 67, 233.
57. Lasky LA. Selectins: interpreters of cell-specific carbohydrate information during inflammation. Science 1992; 258: 964-969.
58. Bevilacqua MP, Nelson RM. Selectins. J Clin Invest 1993; 91: 379-387.
59. Sharon N, Lis H. Lectins as cell recognition molecules. Science 1989; 246: 227-246.
60. Weyrich AS, McIntyre TM, McEver RP, et al. Monocyte tethering by P-selectin regulates monocyte chemotactic protein-1 and tumor necrosis factor-α secretion. Signal integration and NF-Kβ translocation. J Clin Invest 1995; 95: 2297-2303.
61. Cotran RS, Gimbrone M, Bevrilacqua MP, et al. Induction and detection of a human endothelial activation antigen in vivo. J Exp Med 1986; 164: 661-666.
62. Bevilacqua MP, Pober JS, Mendrick DL, et al. Identification of an inducible endothelial-leukocyte adhesion molecule. Proc Natl Acad Sci USA1987; 84: 9238-9242.
63. Bevilacqua MP, Stengelin S, Gimbrone Jr MA et al. Endothelial leukocyte adhesion molecule 1: inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science 1989; 243: 1160-1165.
64. Grober JS, Bowen BL, Ebling H, et al. Monocyte-endothelial adhesion in chronic rheumatoid arthritis. In situ detection of selectin and integrin-dependent interactions. J Clin Invest 1993; 91: 2609-2619.
65. Shimizu Y, Shaw S, Graber N, et al. Activation-independent binding of human memory T cells to adhesion molecule ELAM-1. Nature 1991; 349: 799-802.
66. Erbe DV, Watson SR, Presta LG, et al. P- and E-selectin use common sites for carbohydrate ligand recognition and cell adhesion. J Cell Biol 1993; 120: 1227-1235.
67. Berg EL, Fromm C, Melrose J et al. Antibodies cross-reactive with E- and P-selectin block both E- and P-selectin functions. Blood 1995; 85: 31-37.
68. Gamble JR, Khew-Goodall Y Vadas MA. Transforming growth factor-β inhibits E-selectin expression on human endothelial cells. J Immunol 1993; 150: 4494-4503.
69. Cronstein BN, Kimmel SC, Levin RI, et al. A mechanism for the anti-inflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of ELAM-1 and ICAM-1. Proc Natl Acad Sci USA1992; 89: 9991-9995.
70. von Asmuth EJY, Smeets EF, Ginsel LA, et al. Evidence for endocytosis of E-selectin in human endothelial cells. Eur J Immunol 1992; 22: 2519-2526.
71. Stenberg PE, McEver RP, Shuman MA, et al. A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation. J Cell Biol 1985; 101: 880-886.
72. Crovello CS, Furie BC Furie B. Rapid phosphorylation and selective dephos-phorylation of P-selectin accompanies platelet activation. J Biol Chem 1993; 268: 14590-14593.
73. McEver RP, Beckstead JH, Moore KL, et al. GMP-140, a platelet alpha-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies. J Clin Invest 1989; 84: 92-99.
74. Zimmerman GA, McIntyre TM Prescott SM. Thrombin stimulates the adherence of neutrophils to human endothelial cells in vitro. J Clin Invest 1985; 76: 2235-2246.
75. Geng JG, Bevilacqua MP, Moore KL, et al. Rapid neutrophil adhesion to activated endothelium mediated by GMP-140. Nature 1990; 343: 757-760.
76. Kanwar S, Woodman RC, Poon MC, et al. Desmopressin induces endothelial P-selectin expression and leukocyte rolling in postcapillary venules. Blood 1995; 86: 2760-2766.
77. Larsen E, Celi A, Gilbert GE, et al. PADGEM protein: a receptor that mediates the interaction of activated platelets with neutrophils and monocytes. Cell 1989; 59: 305-312.
78. 2+-dependent adhesion of activated platelets to many different types of leukocytes: detection by flow cytometry. Blood 1992; 80, 134-142.
79. Lalor P, Nash GB. Adhesion of flowing leukocytes to immobilized platelets. Br J Haem 1995; 89: 725-732.
80. Dore M, Korthuis RJ, Granger DN, et al. P-selectin mediates spontaneous leukocyte rolling in vivo. Blood 1993; 82: 1308-1316.
81. Buttrum SM, Hatton R Nash GB. Selectin-mediated rolling of neutrophils on immobilized platelets. Blood 1993; 82: 1165-1174.
82. Mayadas TN, Johnson RC, Rayburn H, et al. Leukocyte rolling and extravazation are severely compromized in P selectin-deficient mice. Cell 1993; 74: 541-554.
83. Mulligan MS, Paulson JC, De Frees S, et al. Protective effects of oligosaccharides in P-selectin-dependent lung injury. Nature 1993; 364: 149-152.
84. Weyrich AS, Ma XI, Lefer DJ, et al. In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischaemia and reperfusion injury. J Clin Invest 1993; 91: 2620-2629.
85. Winn RK, Liggitt D, Vedder NB, et al. Anti-P-selectin monoclonal antibody attenuates reperfusion injury to the rabbit ear. J Clin Invest 1993; 92: 2042-2047.
86. Hallmann R, Jutila MA, Smith CW, et al. The peripheral lymph node homing receptor, LECAM-1, is involved in CD18-independent adhesion of human neutrophils to endothelium. Biochem Biophys Res Commun 1991; 174: 236-243.
87. Ley K, Cerrito M Arfors KE. Sulfated polysaccharides inhibit leukocyte rolling in rabbit mesentery venules. Am J Physiol 1991; 260: H1667-H1673.
88. X-dependent and -independent recognition pathways. Blood 1993; 82: 182-191.
89. Brady HR, Spertini O, Jimenez W, et al. Neutrophils, monocytes, and lymphocytes bind to cytokine-activated kidney glomerular endothelial cells through L-selectin (LAM-1) in vitro. J Immunol 1992; 149: 2437-2444.
90. Kishimoto TK, Warnock RA, Jutila MA, et al. Antibodies against human neutrophil LECAM-1 (LAM-1/Leu-8/DREG-56 antigen) and endothelial cell ELAM-1 inhibit a common CD18-independent adhesion pathway in vitro. Blood 1991; 78: 805-811.
91. Spertini O, Kansas GS, Munro JM, et al. Regulation of leukocyte migration by activation of the leukocyte adhesion molecule-1 (LAM-1) selectin. Nature 1991; 349: 691-694.
92. Kishimoto TK, Jutila MA Butcher EC. Identification of a peripheral lymph node homing receptor: a rapidly down-regulated adhesion molecule. Proc Natl Acad Sci USA1990; 87: 2244-2248.
93. Spertini O, Freedman AS, Belvin MP, et al. Regulation of leukocyte adhesion molecule-1(TQ1, Leu-8) expression and shedding by normal and malignant cells. Leukemia 1991; 5: 300-308.
94. Smith CW, Kishimoto TK, Abbass O, et al. Chemotactic factors regulate lectin adhesion molecule 1 (LECAM-1)-dependent neutrophil adhesion to cytokine-stimulated endothelial cells in vitro. J Clin Invest 1991; 87: 609-618.
95. Kansas GS, Ley K, Munro JM, et al. Regulation of leukocyte rolling and adhesion to high endothelial venules through the cytoplasmic domain of L-selectin. J Exp Med 1993; 177: 833-838.
96. Brandley BK, Swiedler SJ Robbins PW. Carbohydrate ligands of the LEC cell adhesion molecules. Cell 1990; 63: 861-863.
97. Springer TA, Lasky LA. Sticky sugars for selectins. Nature 1991; 349: 196-197.
98. Feizi T. Blood-group related oligosaccharides are ligands in cell-adhesion events. Biochem Soc Trans 1992; 20: 274-278.
99. Lasky LA, Singer MS, Dowbenko D, et al. An endothelial ligand for L-selectin is a novel mucin-like molecule. Cell 1992; 69: 927-938.
100. Haynes BF, Telen MJ, Hale LP, et al. CD44 - a molecule involved in leukocyte adherence and T-cell activation. Immunol Today 1989; 10: 423-428.
101. Dougherty GJ, Lansdorp PM, Cooper DL, et al. Molecular cloning of CD44R1 and CD44R2, two novel isoforms of the human CD44 lymphocyte "homing" receptor expressed by hemopoietic cells. J Exp Med 1991; 174: 1-5.
102. Wayner EA, Carter WG. Identification of multiple cell adhesion receptors for collagen and fibronectin in human fibrosarcoma cells possessing unique a and common β subunits. J Cell Biol 1987; 105: 1873-1884.
103. Miyake K, Underhill CB, Lesley J, et al. Hyaluronate can function as a cell adhesion moelcule and CD44 participates in hyaluronate recognition. J Exp Med 1990; 172: 69-75.
104. Nobis U, Pries AR, Cokelet GR, et al. Radial distribution of white cells during blood flow in small tubes. Microvasc Res 1985; 29: 295-304.
105. Fiebig E, Ley K Arfors KE. Rapid leukocyte accumulation by 'spontaneous' rolling and adhesion in the exteriorized rabbit mesentery. Int J Microcirc 1991; 10: 127-144.
106. Ley K, Gaehtgens P, Fennie C, et al. Lectin-like cell adhesion molecule 1 mediates leukocyte rolling in mesenteric venules in vivo. Blood 1991; 77: 2553-2555.
107. Abbassi O, Kishimoto TK, Mclntire LV, et al. E-selectin supports neutrophil rolling in vitro under conditions of flow. J Clin Invest 1993; 92: 2719-2730.
108. Lawrence MB, Springer TA. Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins. Cell 1991; 65: 859-873.
109. Lawrence MB, Springer TA. Neutrophils roll on E-selectin. J Immunol 1993; 151: 6338-6346.
110. Kuijpers TW, Hakkert BC, Hart MHL, et al. Neutrophil migration across monolayers of cytokine-prestimulated endothelial cells: a role for platelet-activating factor and IL-8. J Cell Biol 1992; 117: 565-572.
111. Griffin JD, Spertini O, Ernst TJ, et al. Granulocyte-macrophage colony-stimulating factor and other cytokines regulate surface expression of the leukocyte adhesion molecule-1 on human neutrophils, monocytes and their precursors. J Immunol 1990; 145: 576-584.
112. Lo SK, Lee S, Ramos RA, et al. Endothelial-leukocyte adhesion molecule 1 stimulates the adhesive activity of leukocyte integrin CR3 (CD11b/CD18, Mac-1, αMβ2) on human neutrophils. J Exp Med 1991; 173: 1493-1500.
113. Lorant DE, Patel KD, McIntyre TM, et al. Coexpression of GMP-140 and PAF by endothelium stimulated by histamine or thrombin: a juxtacrine system for adhesion and activation of neutrophils. J Cell Biol 1991; 115: 223-234.
114. Yong KL, Linch DC. Differential effects of granulocyte- and granulocyte-macrophage colony-stimulating factors (G- and GM-CSF) on neutrophil adhesion in vitro and in vivo. Eur J Haematol 1992; 49: 251-259.
115. Yong KL, Linch DC. Granulocyte-macrophage-colony-stimulating factor differentially regulates neutrophil migration across IL-1-activated and nonactivated human endothelium. J Immunol 1993; 150: 2449-2456.
116. Zimmerman GA, McIntyre TM. Neutrophil adherence to human endothelium in vitro occurs by CDw18 (Mol, MAC-1/LFA-1/GP 150,95) glycoprotein-dependent and -independent mechanisms. J Clin Invest 1988; 81: 531-537.
117. Luscinkas FW, Brock AF, Arnaout MA, et al. Endothelial-leukocyte adhesion molecule-1-dependent and leukocyte (CD11/CD18)-dependent mechanisms contribute to polymorphonuclear leukocyte adhesion to cytokine-activated human vascular endothelium. J Immunol 1989; 142: 2257-2263.
118. Luscinkas FW, Cybulsky MI, Kiely JM, et al. Cytokine-activated human endothelial monolayers support enhanced neutrophil transmigration via a mechanism involving both endothelial-leukocyte adhesion molecule-1 and intercellular adhesion molecule-1. J Immunol 1991; 146: 1617-1625.
119. Habbal MHEI, Strobel S. Leukocyte adhesion deficiency. Arch Dis in Childhood 1993; 69: 463-466.
120. Carlos TM, Schwartz BR, Kovach NL, et al. Vascular cell adhesion molecule-1 mediates lymphocyte adherence to cytokine-activated cultured human endothelial cells. Blood 1990; 76: 965-970.
121. Schwartz BR, Wayner EA, Carlos TM, et al. Identification of surface proteins mediating adherence of CD11/CD18-deficient lymphoblastoid cells to cultured human endothelium. J Clin Invest 1990; 85: 2019-2024.
122. Pelletier RP, Ohye RG, Vanbuskirk A, et al. Importance of endothelial VCAM-1 for inflammatory leukocytic infiltration in vivo. J Immunol 1992; 14: 2473-2481.
123. 1 integrin (VLA-4) affinity. J Cell Science 1993; 104: 1049-1059.
124. Winn RK, Harlan JM. CD18-independent neutrophil and mononuclear leukocyte emigration into the peritoneum of rabbits. J Clin Invest 1993; 92: 1168-1173.
125. Horst E, Meijer CJ, Radaszkiewicz T, et al. Adhesion molecules in the prognosis of diffuse large-cell lymphoma: expression of a lymphocyte homing receptor (CD44), LFA-1 (CD11a/18), and ICAM-1. Leukemia 1990; 4: 595-599.
126. Picker LJ, Warnock RA, Burns AR, et al. The neutrophil selectin LECAM-1 presents carbohydrate ligands to the vascular selectins ELAM-1 and GMP-140. Cell 1991; 66: 921-933.
127. Salmi M, Jalkanen S. A 90-kilodalton endothelial cell molecule mediating lymphocyte binding in humans. Science 1992; 257, 1407-1409.
128. Gibson RM, Scopes J, Daly S, et al. Hemopoietic growth factor production by normal and aplastic anaemia stroma in long-term bone marrow culture. Br J Haematol 1995; 91: 551-561.
129. Torok-Storb B. Cellular interactions. Blood 1988; 72: 373-385.
130. Otsuka T, Thacker D Hogge D. The effects of interleukin 6 and interleukin 3 on early hematopoietic events in long-term cultures of human marrow. Exp Hematol 1991; 19: 1042-1048.
131. Gordon MY, Riley GP, Watt SM, et al. Compartmentalization of a haematopoietic growth factor (GM-CSF) by glycosaminoglycans in the bone marrow microenvironment. Nature 1987; 326: 403-405.
132. Stein J, Borzillo GV Rettenmier CW. Direct stimulation of cells expressing receptors for macrophage colony stimulating factor (CSF-1) by a plasma membrane bound precursor of CSF-1. Blood 1990; 76: 1308-1314.
133. Flanagan JG, Leder P. The kit ligand: a cell surface molecule altered in Steel mutant fibroblasts. Cell 1990; 63: 185-194.
134. Long MW, Briddell R, Walter AW, et al. Human hematopoietic stem cell adherence to cytokines and matrix molecules. J Clin Invest 1992; 90: 251-255.
135. Bruno E, Luikart SD, Long MW, et al. Marrow-derived heparan sulfate proteoglycan mediates the adhesion of hematopoietic progenitor cells to cytokines. Exp Hematol 1995; 23: 1212-1217.
136. Cashman J, Eaves AC Eaves CJ. Regulated proliferation of primitive hematopoietic progenitor cells in long-term human marrow cultures. Blood 1985; 66: 1002-1005.
137. Oostendorp RAJ, Reisbach G, Spitzer E, et al. VLA-4 and VCAM-1 are the principal adhesion molecules involved in the interaction between blast colony-forming cells and bone marrow stromal cells. Br J Haematol 1995; 91: 275-284.
138. Kerst JM, Sanders JB, Slaper-Cortenbach ICM, et al. α4β1 and α5β1 are differentially expressed during myelopoiesis and mediate the adherence of human CD34+ cells to fibronectin in an activation-dependent way. Blood 1993; 81: 344-351.
139. Reuss-Borst MA, Buhring HJ, Klein G, et al. Adhesion molecules on CD34+ hematopoietic cells in normal human bone marrow and leukemia. Ann Hematol 1992; 65: 169-174.
140. Liesveld JL, Winslow JM, Frediani KE, et al. Expression of integrins and examination of their adhesive function in normal and leukaemic hematopoietic cells. Blood 1993; 81: 112-121.
141. Lund-Johansen F, Terstappen LWMM. Differential surface expression of cell adhesion molecules during granulocyte maturation. J Leukoc Biol 1993; 54: 47-55.
142. Patel VP, Lodish HF. Loss of adhesion of murine erythroleukaemia cells to fibronectin during erythroid differentiation. Science 1984; 224: 996-998.
143. Patel VP, Ciechanover A, Platt O, et al. Mammalian reticulocytes lose adhesion to fibronectin during maturation to erythrocytes. Proc Natl Acad Sci USA 1985; 82: 440-446.
144. Patel VP, Lodish HF. A fibronectin matrix is required for differentiation of murine erythroleukaemia cells into reticulocytes. J Cell Biol 1987; 105: 3105-3109.
145. Jarvinen M, Ylanne J Virtanen I. The effect of differentiation inducers on the integrin expression of K562 erythroleukemia cells. Cell Biol Int 1993; 17: 399-407.
146. Miyake K, Medina KL, Hayashi SI, et al. Monoclonal antibodies to Pgp-1/CD44 block lympho-hemopoiesis in long-term bone marrow cultures. J Exp Med 1990; 171: 477-488.
147. Zuckerman KS, Rhodes RK, Goodwin DD, et al. Inhibition of collagen deposition in the extracellular matrix prevents the establishment of a stroma supportive of hematopoiesis in long-term murine bone marrow cultures. J Clin Invest 1985; 75: 970-975.
148. Campbell AD, Long MW Wicha MS. Haemonectin, a bone marrow adhesion protein specific for cells of granulocyte lineage. Nature 1987; 329: 744-746.
149. Peters C, O'Shea KS, Campbell AD, et al. Fetal expression of hemonectin: an extracellular matrix hematopoietic cytoadhesion molecule. Blood 1990; 75: 357-364.
150. Saville J, Dransfield I, Hogg N, et al. Vitronectin-receptor mediated phagocytosis of cells undergoing apoptosis. Nature 1993; 343: 170-173.
151. Dransfield I, Stocks SC Haslett C. Regulation of cell adhesion molecule expression and function associated with neutrophil apoptosis. Blood 1995; 85: 3264-3273.
152. Lowdell MW, Shamim F, Hamon M, et al. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation. Exp Hematol 1995; 23: 1530-1534.
153. Jalkanen S, Joensu H, Soderstrom KO, et al. Lymphocyte homing and clinical behaviour of non-Hodgkin's lymphoma. J Clin Invest 1992; 87: 1835-1840.
154. Zalhalka MA, Okon F Naor D. Blocking lymphoma invasiveness with a monoclonal antibody directed against the β-chain of the leukocyte adhesion molecule (CD18). J Immunol 1993; 150: 446664477.
155. Stauder R, Greil R, Schulz TF, et al. Expression of leukocyte function-associated antigen-1 and 7F7-antigen and adhesion molecule related to intercellular adhesion molecule-1 (ICAM-1) in non-Hodgkin's lymphomas and leukaemias: possible influence on growth pattern and leukaemic behaviour. Clin Exp Immunol 1989; 77: 234-238.
156. Gordon MY, Dowding CR, Riley GP, et al. Altered adhesive interactions with marrow stroma of hemopoietic progenitor cells in chronic myeloid leukaemia. Nature 1987; 328: 342-344.
157. Gordon MY, Atkinson J, Clarke D, et al. Deficiency of a phosphatidylinositol-anchored cell adhesion molecule influences hemopoietic progenitor binding to marrow stroma in chronic myeloid leukemia. Leukemia 1991; 5: 693-698.
158. Dowding C, Guo A-P, Osterholz J, et al. Interferon-a overrides the deficient adhesion of chronic myeloid leukemia primitive progenitor cells to bone marrow stromal cells. Blood 1991; 78: 499-505.
159. Verfaillie CM, McCarthy JB McGlave PB. Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogeneous leukaemia. J Clin Invest 1992; 90: 1232-1241.
160. van Beek WP, Smets LA Emmelot P. Changed surface glycoprotein as a marker of malignancy in human leukaemic cells. Nature 1975; 253: 457-460.
161. Denkers IAM, Beelen RHJ, Ossenkoppele GJ, et al. Differences of cellular composition and adhesion molecule expression in "leukemic" as compared with "normal" human long-term bone marrow cultures. Ann Hematol 1992; 64: 210-216.
162. Cavenagh JD, Gordon-Smith EC, Gibson FM et al. Acute myeloid leukaemia blast cells bind to human ednothelium in vitro utilising E-selectin and vascular cell adhesion molecule-1 (VCAM-1). Br J Haem 1994; 85: 285-292.
163. Cavenagh JD, Gordon-Smith EC Gordon MY. The binding of acute myeloid leukacmia blast cells to endothelium Leuk Lymphoma 1994; 16: 19-29.
164. Palucka AK, Porwit A Reizenstein P. Resistance of leukemic blasts to lymphokine activated killer (LAK)-mediated cytotoxicity is not related to their adhesion properties. Eur J Haematol 1991; 47: 123-127.
165. Vila L, Thomas X, Campor L, et al. Expression of VLA molecules on acute leukemia cells: relationship with disease characteristics. Exp Hematol 1995; 23: 514-518.
166. Reuss-Borst MA, Ning Y, Klein G, et al. The vascular cell adhesion molecule (VCAM-1) is expressed on a subset of lymphoid and myeloid leukaemias. Br J Haematol 1995; 89: 299-305.
167. Baker MA, Taub RN, Whetton CH, et al. Aberrant sialylation of granulocyte membranes in chronic myelogeneous leukaemia. Blood 1984; 63: 1194-7.
168. Baker MA, Taub RN, Kanani A, et al. Increased activity of a specific sialyltransferase in chronic myelogeneous leukaemia. Blood 1985; 66: 1068-71.
169. Prystas EM, Parker CJ, Holguin MH, et al. Aberrant glycosylation of L-selectin on the lymphocytes of chronic lymphocytic leukemia. Leuk 1993; 7: 1355-1362.
170. Denkers IAM, de Jong-de Boer TJM, Beelen RHJ, et al. VLA molecule expression may be involved in the release of acute myeloid leukaemic cells from the bone marrow. Leuk Res 1992; 16: 469-474.
171. Denkers IAM, de Jong-de Boer TJM, Beelen RHJ, et al. Adhesive capacity of human long-term bone marrow cultures from normals and patients with acute myeloid leukaemia: the influence of adhesion molecules. Leuk Res 1993; 17: 255-261.
172. Bourne HR, Sanders DA McCormick F. The GTPase super family: a conserved switch for diverse cell functions. Nature 1990; 348: 125-132.
173. Mulcahy LS, Smith MR Stacey DW. Requirement for ras proto-oncogene function during serum-stimulated growth of NIH 3T3 cells. Nature 1985; 313: 241-243.
174. Radinsky R, Flickinger KS, Kosir MA, et al. Adhesion of Kirsten-ras+ tumor-progressing and Kirsten-ras-revertant 3T3 cells on fibronectin proteolytic fragments. Cancer Res 1990; 50: 4388-4400.
175. Plantefaber LC, Hynes RO. Changes in integrin receptors on oncogenically transformed cells. Cell 1989; 56: 281-290.
176. Shirasawa S, Furuse M, Yokoyama N, et al. Altered growth of human colon cancer cell lines disrupted at activated Ki-ras. Science 1993; 260: 85-88.
177. Easton EW, Bolscher JGM van den Eijnden DH. Enzymatic amplification involving glycosyltransferases forms the basis for the increased size of aspar-agine-linked glycans at the surface of NIH 3T3 cells expressing the N-ras proto-oncogene. J Biol Chem 1991; 266: 21674-21680.
178. Schlaepfer DD, Hanks SK, Hunter T, et al. Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature 1994; 372: 786-791.
179. Page C. Platelets as inflammatory cells, Immunopathology 1989; 17: 51-59.
180. Joseph M, Auriault C, Capron A, et al. A new function for platelets: IgE-dependent killing of schistosomes. Nature 1983; 303: 810-812.
181. deGroot PG. Platelet adhesion. Br J Haematol 1990; 75: 308-312.
182. Siess W. Molecular mechanisms of platelet activation. Physiol Rev 1989; 6: 58-178.
183. Iwanaga S. Primitive coagulation systems and their message to modern biology. Thromb Haemostas 1993; 70: 48-55.
184. Deuel TF, Senior RM Huang JS. Chemotaxis of monocytes and neutrophils to platelet derived growth factor. J Clin Invest 1982; 69: 1046-49.
185. Saxena SP, Brandes LJ, Becker AB, et al. Histamine is an intracellular messenger mediating platelet aggregation. Science 1989; 243: 1596-1599.
186. Lorant DE, Topham KM, Whatley RE, et al. Inflammatory roles of P selectin. J Clin Invest 1993; 92: 559-570.
187. Kaplanski G, Porat R, Aiura Koichi, et al. Activated platelets induce endothelial secretion of interleukin-8 in vitro via an interleukin-1 mediated event. Blood 1993; 81: 2492-2495.
188. 125I-Fibrinogen binding to platelets in myeloproliferative disorders. Thromb Haemost 1991; 66: 329-333.
189. Marguerie GA, Ginsberg MH Plow EF. Fibrinogen and platelet function (review). Adv Exp Med Biol 1985; 192: 41-54.
190. Bennett JS. Integrin structure and function in hemostasis and thrombosis. Ann NY Acad Sci. 1991; 614: 214-228.
191. Shattil SJ, Cunningham N Hoxie JA. Detection of activated human platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood 1987; 70: 307-315.
192. Sims PJ, Ginsberg MH, Plow EF, et al. Effect of platelet activation on the conformation of the plasma membrane glycoprotein GPIIb/IIIa complex. J Biol Chem 1991; 266: 7345-52.
193. Coller BS, Folts JD, Smith BS, et al. Abolition of in vivo platelet thrombus formation in primates with monoclonal antibodies to platelet GPIIb/IIIa receptor. Circulation 1989; 80: 1766-1774.
194. Plow EF, Ginsberg MH. Cellular adhesion: GPIIb/IIIa as a prototypic adhesion receptor. Prog Hemostas Thromb 1988; 296: 320-331.
195. McEver RP, Martin MN. A monoclonal antibody to a membrane glycoprotein binds only to activated platelets. J Biol Chem 1984; 259: 9799-9804.
196. Hsu-Lin S-C, Berman CL, Furie BC, et al. A platelet membrane protein expressed during platelet activation and secretion. Studies using a monoclonal antibody specific for thrombin activated platelets. J Biol Chem 1984; 259: 9121-9126.
197. Fairburn RA. Aetiology of ulcerative colitis: a vascular hypothesis. Lancet 1973; 2: 697-9.
198. Wakefield AJ, Sawyer AM, Dhillon AP, et al. Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction. Lancet 1989; 2: 1057-1062.
199. Talbot RW, Heppel J, Dozois RR, et al. Vascular complications of inflammatory bowel disease. Mayo Clin Proc 1986; 61: 140-145.
200. Collins CE, Cahill MR Newland AC. Circulating platelets are activated in inflammatory bowel disease. Increased platelet aggregation in inflammatory bowel disease (IBD). Gasteroenterology 1994; 106: 840-845.
201. Deuel TF, Senior RM Huang JS. Chemotaxis of monocytes and neutrophils to platelet derived growth factor. J Clin Invest 1982; 69: 1046-49.
202. Collins CE, Rampton DS. Platelet dysfunction; a new dimension in inflammatory bowel disease. Gut 1995; 36: 5-8.
203. Coller BS, Peerschke EI, Scudder LE, et al. Studies with a murine monoclonal antibody that abolishes ristocetin induced binding of von Willebrand factor to platelets: additional evidence in support of GPIb as a platelet receptor for von Willebrand factor. Blood 1983; 61: 99-110.
204. Du X, Beutler L, Ruan C, et al. Glycoprotein Ib and glycoprotein IX are fully complexed in the intact platelet membrane. Blood 1987; 69: 1524-7.
205. Jamieson GA. The activation of platelets by thrombin: a model for activation by high and moderate affinity receptor pathways. Prog Clin Biol Res 1988; 283: 137-58.
206. Glanzmann E. Hereditäre hämorrhagische Thrombasthenie. Ein Beitrag zur Plättchen J Kinderkr 1918; 88: 1.
207. George JN, Nurden AT Phillips DR. Molecular defects in interactions of platelets with the vessel wall. N Engl J Med 1984; 311: 1084-98.
208. Larrieu MJ, Caen JP, Meyer DO, et al. Congenital bleeding disorders with long bleeding time and normal platelet count. Am J Med 1968; 45: 354-72.
209. Bernard J, Soulier JP. Sur une nouvelle variete de dystrophie thrombocytaire-hemorragipare congenitale. Semin d'Hop Paris 1948; 24: 3217-3223.
210. Nurden AT, Caen JP. Specific roles for platelet surface glycoprotein in platelet function. Nature 1975; 255: 720-22.
211. Clemetson KJ, McGregor JL, James E, et al. Characterization of the platelet membrane glycoprotein abnormalities in Bernard-Soulier syndrome and comparison with normal by surface labelling techniques and high-resolution two-dimensional gel electrophoresis. J Clin Invest 1982; 70: 304-11.
212. Etzioni A, Frydman M, Pollack S, et al. Brief Report: Recurrent severe infections caused by a novel leukocyte adhesion deficiency. N Engl J Med 1992; 327: 1789-1792.
213. Rosa JP, George JN, Bainton DF, et al. Gray platelet syndrome. Demonstration of alpha granule membranes that can fuse with the cell surface. J Clin Invest 1987; 80: 1138.
214. Haskard DO. Cell adhesion molecules in rheumatoid arthritis. Curr Opin Rheumatol 1995; 7: 229-34.
215. Kavanaugh AF, Davis LS, Nichols LA, et al. Treatment of refractory rheumatoid arthritis with a monoclonal antibody to ICAM 1. Arthritis Rheum 1994; 37: 992-9.
216. Yednock TA, Cannon C, Fritz LC, et al. Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. Nature 1992; 356(6364): 63-6.
217. Baron J, Madri JL, Ruddle NH, et al. Surface expression of the a4 integrin by CD4 T cells is required for their entry into brain parenchyma. J Exp Med 1993; 177: 57-68.
218. Abraham WM, Sielczak MW, Ahmed A, et al. A4 integrins mediate antigen-induced late bronchial responses and prolonged airway hyperresponsiveness in sheep. J Clin Invest 1994; 93: 776-787.
219. Nakajima H, Sano H, Nishimura T, et al. The role of VCAM-1/VLA-4 and ICAM-1/LFA-1 interactions in antigen-induced eosinphil and T cell recruitment into tissue. J Exp Med 1994; 179: 1145-1154.
220. Pretolani M, Ruffie C, Lapa e Silva JR, et al. Antibody against VLA4 prevents antigen-induced bronchial hyperreactivity and celluar infiltration in guinea pig airways. J Exp Med 1994; 180: 795-805.
221. Podolsky D, Lobb KR, King N, et al. Attenuation of colitis in the cotton top tamarin by anti-a4 integrin monoclonal antibody. J Clin Invest 1993; 92: 372-380.
222. Peake S. Monoclonal antibodies - immunotherapy for the critically ill. Anaesth Intens Care 1993; 21: 739-51.
223. Behar E, Chao NJ, Hiraki DD, et al. Polymorphism of adhesion molecule CD31 and its role in acute graft versus host disease. N Engl J Med 1996; 334: 286-91.
224. Schlegel PG, Vaysburd M, Chen Y, et al. Inhibition of T cell costimulation by VCAM-1 prevents murine graft versus host disease across minor histocompatibility barriers. J Immunol 1995; 155: 3856-3865.
225. Van Dijken PJ, Ghayur T, Mauch P, et al. Evidence that anti-LFA1 in vivo improves engraftment and survival after allogeneic bone marrow transplantation. Transplantation 1990; 49: 882-886.
226. Fischer A, Freidrich W, Blanche S, et al. Reduction of graft failure by a monoclonal antibody (antiLFA1-CD11a) after HLA non-identical bone marrow transplant with inborn errors. Blood 1991; 77: 249-256.
227. Baume D, Kuentz M Pico JL. Failure of a CD18/anti-LFA1 monoclonal antibody infusion to prevent graft rejection in leukemic patients receiving T depleted allogeneic bone marrow transplantation. Transplantation 1989; 47: 472-4.
228. Le Mauff B, Hourmant M, Le Meur Y, et al. Anti-LFA1 adhesion molecule antibody in prophylaxis of human kidney allograft rejection. Transplant Proc 1995; 27: 965-6.
229. Isobe M, Yagita H, Okamura K, et al. Specific acceptance of cardiac allograft after treatment with antibodies to ICAM 1 and LFA1. Science 1992; 255: 1125-7.
230. Mulligan MS, Polley MJ, Bayer RJ, et al. Neutrophil-dependent acute lung injury. Requirement for P-selectin (GMP-140). J Clin Invest 1992; 90: 1600-1607.
231. Christopoulos C, Mackie I, Lahiri A, et al. Flow cytometric observation on the in vivo use of Fab fragments of a chimaeric monoclonal antibody to platelet glycoprotein IIb/IIIa. Blood Coag Fibrinol 1993; 4: 729-37.
232. 2 fragments of murine monoclonal antibody directed against human platelet glycoproteins GPIIb/IIIa in patients with unstable angina pectoris. J Clin Invest 1990; 86: 651-659.
233. EPIC investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994; 330: 956-961.
234. The CAPTURE investigatiors. Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angine: the CAPTURE study, Lancet 1997; 349: 1429-1435.
235. Topol EJ, Califf RM, Weisman HF, et al. and the EPIC investigators. Randomized trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at 6 months. Lancet 1994; 343: 881-886.
236. Cahill MR, Macey MG, Dawson JR, et al. Prevention of restenosis after angioplasty. Lancet 1994; 343: 136.
237. Weiss EJ, Bray PF, Tayback M, et al. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med 1996; 334: 1090-1091.